Mangoceuticals (MGRX) Intangibles (2024 - 2026)

Mangoceuticals has disclosed Intangibles across 3 years of filings, most recently posting $13.6 million for Q2 2026.

• In Q2 2026, Intangibles fell 34.06% year-over-year to $13.6 million; the TTM figure through Jun 2026 stood at $13.6 million (down 34.06% YoY), while the FY2025 annual figure was $14.2 million, down 6.57% from the prior year.
• Intangibles came in at $13.6 million for Q2 2026 at Mangoceuticals, down from $13.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $21.5 million in Q1 2025 to a low of $13.6 million in Q2 2026.
• Average Intangibles over 3 years is $16.0 million, with a median of $14.6 million recorded in 2024.
• Year-over-year, Intangibles jumped 41.65% in 2025 and tumbled 35.25% in 2026.
• Over 3 years, Intangibles stood at $15.2 million in 2024, then decreased by 6.57% to $14.2 million in 2025, then declined by 4.12% to $13.6 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $13.6 million in Q2 2026, $13.9 million in Q1 2026, and $14.2 million in Q4 2025.